Navigation Links
Emphysema surgery - unfavourable,,

Lung reduction surgery for emphysema does not help the sickest patients, according to the latest report. In emphysema, the air sacs of the lungs - the alveoli - are progressively destroyed,// leaving the patient so short of breath that they cannot do everyday activities like climbing stairs or carrying their shopping. In the mid-1990s, studies seemed to suggest that lung reduction surgery was beneficial for people with emphysema. It appeared to leave them with a smaller, but more efficient, lung by cutting out a lot of the diseased tissue.

Following this report, the demand for surgery increased enormously and the National Institutes of Health launched further trials to see if the operation was really effective. People had either surgery or standard medical management for their condition. The first report of the trial now urges caution over surgery. The sickest patients - those with the worst lung function- have a higher risk of death within 30 days of the operation compared to those who don't have surgery. Whether those who survive surgery will do better than those on medical management in the long term remains to be seen. In the meantime, it appears that surgery should not be regarded as a universal solution for emphysema.


'"/>




Page: 1

Related medicine news :

1. Emphysema surgery - unbeneficial
2. African Americans Have Increased Risk Of Emphysema
3. LVRS Increases Survival Rates among Emphysema Patients
4. Novel Airway Bypass Treatment Assists Emphysema Sufferers
5. Thyroid hormone treatment hastens recovery after cardiac surgery
6. Two doctors suspended for wrong brain surgery
7. Researchers urge caution in using ear tube surgery
8. Sweaty palms syndrome can be cured by surgery
9. Surviving surgery
10. Waking during surgery
11. Supplement helps cardiac surgery
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Emphysema surgery unfavourable

Other Medicine News:Health News:Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford 2Health News:American Kidney Fund Issues Appeal for Disaster Relief Contributions 2Health News:American Kidney Fund Issues Appeal for Disaster Relief Contributions 3Health News:SpectraScience Delivers Cancer Diagnosis System to Mayo Clinic and UCSD/VA for Detecting Esophageal Dysplasia in Patients 2Health News:SpectraScience Delivers Cancer Diagnosis System to Mayo Clinic and UCSD/VA for Detecting Esophageal Dysplasia in Patients 3Health News:HTH Worldwide to Provide Mobile Healthcare Tool to HRG North America's Affiliate Program 2Health News:HTH Worldwide to Provide Mobile Healthcare Tool to HRG North America's Affiliate Program 3Health News:Merck's odanacatib increased BMD over 2 years at key fracture sites in Phase IIB study 2Health News:Merck's odanacatib increased BMD over 2 years at key fracture sites in Phase IIB study 3Health News:Estrogen Cream No Match for Sun-Damaged Skin 2
Breaking Medicine Technology:Indiana Blood Center Taps tw telecom for Data, Internet and IP Telephony Services 2National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 1Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 1National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 2National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 3National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 4National Expressions of Courage Art Contest Unveils Stories of Inspiration 6277 5Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 1Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 2Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 3Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 4Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 5Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 6Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 7Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 8Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 9Lotus Pharmaceuticals Inc Reports Third Quarter 2009 Results 6274 10
Other Medicine Technology:Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 2Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 3Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 4Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 5Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 6Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 7Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 8Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 2Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 3Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine,in Glioma Presented at American Association of Neurological,Surgeons Annual Meeting 4